参考文献/References:
[1] ZHANG C,WANG C.Expression profile of microRNAs in serum:a fingerprint for esophageal squamous cell carcinoma[J].Clin Chem,2010,56(12):1871-1879.
[2] O′HAYRE M,SALANGA C L,HANDEL T M,et al.Chemokines and cancer:migration,intracellular signalling and intercellular communication in the microenvironment[J].Biochem J,2008,409(3):635-649.
[3] BURNS J M,SUMMERS B C,WANG Y,et al.A novel chemokine receptor for SDF-l and I-TAC involved in cell survival,cell adhesion,and tumor development[J].J Exp Med,2006,203(9):2201-2213.
[4] MIAO Z,LUKER K E,SUMMERS B C,et al.CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature[J].Proc Natl Acad Sci USA,2007,104 (40):15735-15740.
[5] XUE T C,CHEN R X,HAN D,et al.Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential[J].Exp Ther Med,2012,3 (1):117-123.
[6] WANG J,SHIOZAWA Y,WANG J,et al.The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer[J].J Biol Chem,2008,283(7):4283-4294.
[7] ZHENG K,LI H Y,SU X L,et al.Chemokine receptor CXCR7 regulates the invasion,angiogenesis and tumor growth of human hepatocellular carcinoma cells[J].J Exp Clin Cancer Res,2010,29:31.
[8] HEINRICH E L,LEE W,LU J,et al.Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells[J].J Transl Med,2012,10:68.
[9] LEVOYE A,BALABANIAN K,BALEUX F,et al.CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling[J].Blood,2009,113(24):6085-6093.
[10] LUKER K E,LEWIN S A,MIHALKO L A,et al.Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells[J].Oncogene,2012,31(45):4750-4758.
[11] BOLDAJIPOUR B,MAHABALESHWAR H,KARDASH E,et al.Control of chemokine-guided cell migration by ligand sequestration[J].Cell,2008,132(3):463-473.
[12] SCHONEMEIER B,SCHULZ S,HOELLT V,et al.Enhanced expression of the CXCL12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain[J].J Neuroimmunol,2008,198(1/2):39-45.
[13] KALATSKAYA I,BERCHICHE Y A,GRAVEL S,et al.AMD3100 is a CXCR7 ligand with allosteric agonist properties[J].Mol Pharmacol,2009,75(5):1240-1247.
相似文献/References:
[1]原志庆,王凤荣,吴国祥,等.食管癌切除标本断端残留癌的流式细胞分析[J].新乡医学院学报,1991,8(01):012.
[2]彭明轩,张一峰.食管癌与贲门癌238例手术治疗及其并发症分析[J].新乡医学院学报,1992,9(01):048.
[3]刘玉梅,申维玺,姚卫华,等.氟尿嘧啶合并醛氢叶酸治疗食管癌疗效评价[J].新乡医学院学报,1995,12(02):123.
[4]原志庆,许春雷.瘤体内DNA倍体异质性与食管鳞状细胞癌病理特性的关系[J].新乡医学院学报,1995,12(01):005.
[5]常银江,马森林,王守义,等.上段食管癌切除后食管床内胃食管颈部吻合术[J].新乡医学院学报,1996,13(02):143.
[6]王俊英,李国群,董长宪,等.食管癌合并糖尿病患者的围手术期处理[J].新乡医学院学报,1996,13(02):151.
[7]陈国荣.中晚期食管癌夹心治疗近期疗效分析 [J].新乡医学院学报,1997,14(02):150.
[8]李慧清,李汉臣,杨红伟,等.不同食管胃吻合方法术后生活质量分析[J].新乡医学院学报,1997,14(03):213.
[9]郭玉军,吴阶清,刘新秋,等.双介入疗法治疗晚期食管癌[J].新乡医学院学报,1997,14(03):287.
[10]乔 刚 李汉臣 席红军 王忠民 崔 玉 韩培立 赵宝生.食管癌患者手术前后细胞免疫的变化[J].新乡医学院学报,1999,16(04):308.